Skip to main content
CMTG $1.82 -4.21%
CMTG logo

CMTG · Claros Mortgage Trust, Inc.

Track CMTG — free
$1.82 -0.08 (-4.21%) At close · Aug 14
Market Cap
$256.77M
Shares
141.08M
All earnings calls

Earnings call · FY2025 Q4

Claros Mortgage Trust, Inc. Q4 FY2025 Earnings Call

Claros Mortgage Trust, Inc. Q4 FY2025 Earnings Call

Concluded Feb 19, 2026 Audio replay
Feb 19, 2026 38:33 29 turns
Period
FY2025 Q4
Runtime
38:33
Sources
5 artifacts

Executive readout · one minute

What matters this quarter

Claros Mortgage Trust reported a Q4 2025 GAAP net loss of $1.56 per share and distributable loss of $0.71 per share while exceeding its $2 billion 2025 resolution target with $2.5 billion of UPB resolutions, retiring its Term Loan B with a new $500 million HPS facility maturing in 2030, and further delevering its loan portfolio to $3.7 billion.

REO portfolio and asset management 28 Loan resolutions and watchlist progress 25 Liquidity position 20 Deleveraging and balance sheet management 18 Corporate debt refinancing 13 Future origination and growth strategy 6

Management tone

Positive

Net tone +35 · moderate hedging

Grounding quotes
  • “we exceeded our $2 billion loan UPB resolution target, achieving $2.5 billion of UPB and resolutions for the year”
  • “we are really excited to be feeling like we can see the light at the end of the tunnel and that the capital markets are cooperating with us”
  • “the market has not fully recovered. Transaction volume remains lower than we anticipated at this point”

Research coverage

5 live sources

Switch sources without leaving this page or losing your listening position.

Revenue · derived Q4 $46.75M -22.4% YoY
Net income · derived Q4 -$219.21M

Research materials

Open the source you need; every reader stays inside this workspace.

Key takeaways

What improved, and what deserves a closer read.

Constructive signals

  • Exceeded 2025 resolution target of $2 billion, achieving $2.5 billion in UPB resolutions including 11 watchlist loans totaling $1.3 billion in UPB
  • Retired Term Loan B and replaced it with a new $500 million senior secured loan from HPS with 4-year duration extending corporate debt maturity to 2030
  • Generated $389 million of additional resolutions in early 2026 across four loans, including a previously nonaccrual NYC land loan watchlist resolved
  • Resolved a $150 million Connecticut office watchlist loan via discounted payoff at ~70% of par, generating ~$35 million of net liquidity used to reduce debt
  • Reduced portfolio UPB from $6.1 billion at year-end 2024 to $3.7 billion at Q4 2025, exiting stand-alone life science and reducing office exposure from $859 million to $589 million and land from $489 million to $187 million
  • Total liquidity of $185 million including $173 million cash and $541 million of unencumbered assets at year-end

Risks & pressure points

  • Reported GAAP net loss of $219.2 million ($1.56/share) for Q4 2025 and $489.1 million ($3.49/share) for full year 2025
  • Reported distributable loss of $101.7 million ($0.71/share) for Q4 2025 and $269.0 million ($1.88/share) for full year 2025
  • Recorded $211.7 million ($1.48/share) CECL provision in Q4, with total CECL reserves of $443.1 million or ~10.9% of UPB at year-end
  • Discounted payoff on $150 million office loan resulted in a $46 million principal charge-off
  • Loan portfolio declining through repayments and resolutions with no timeline yet for new originations; company targets evaluating new lending only toward end of 2026
  • Management flagged expected decline in net interest income as performing loans repay and recognized that transaction volume 'remains lower than we anticipated'

Key moments

Jump directly to management's words in the synchronized transcript.

“We view this financing agreement with HPS as a positive for CMTG as it extends the maturity of our corporate debt to 2030 and provides the necessary flexibility to continue executing our business plan of resolving watchlist loans, delevering our balance sheet and reducing our capital costs over time.” Richard Mack, CEO
“By the end of this year, we are assessing various capital allocation options for our available liquidity, which may include originating new loans, further reducing balance sheet leverage, or exploring other capital allocation alternatives.” Mike McGillis, CFO
Full-screen source Call document